485 related articles for article (PubMed ID: 17031387)
21. Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.
Buss JL; Neuzil J; Ponka P
Arch Biochem Biophys; 2004 Jan; 421(1):1-9. PubMed ID: 14678779
[TBL] [Abstract][Full Text] [Related]
22. Iron chelation abrogates excessive formation of hydroxyl radicals and lipid peroxidation products in monocytes of patients with Eales' disease: direct evidence using electron spin resonance spectroscopy.
Rajesh M; Sulochana KN; Ramakrishnan S; Biswas J; Manoharan PT
Curr Eye Res; 2004 Jun; 28(6):399-407. PubMed ID: 15512947
[TBL] [Abstract][Full Text] [Related]
23. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
Santos NC; Castilho RF; Meinicke AR; Hermes-Lima M
Eur J Pharmacol; 2001 Sep; 428(1):37-44. PubMed ID: 11779035
[TBL] [Abstract][Full Text] [Related]
24. Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.
Maurício AQ; Lopes GK; Gomes CS; Oliveira RG; Alonso A; Hermes-Lima M
Biochim Biophys Acta; 2003 Mar; 1620(1-3):15-24. PubMed ID: 12595068
[TBL] [Abstract][Full Text] [Related]
25. Deferiprone protects against doxorubicin-induced myocyte cytotoxicity.
Barnabé N; Zastre JA; Venkataram S; Hasinoff BB
Free Radic Biol Med; 2002 Jul; 33(2):266-75. PubMed ID: 12106822
[TBL] [Abstract][Full Text] [Related]
26. EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on *OH formation by the Fenton reaction.
Hermes-Lima M; Santos NC; Yan J; Andrews M; Schulman HM; Ponka P
Biochim Biophys Acta; 1999 Feb; 1426(3):475-82. PubMed ID: 10076064
[TBL] [Abstract][Full Text] [Related]
27. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
[TBL] [Abstract][Full Text] [Related]
28. Doxorubicin reduces the iron(III) complexes of the hydrolysis products of the antioxidant cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl radicals.
Malisza KL; Hasinoff BB
Arch Biochem Biophys; 1995 Feb; 316(2):680-8. PubMed ID: 7864623
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis.
Hruskova K; Kovarikova P; Bendova P; Haskova P; Mackova E; Stariat J; Vavrova A; Vavrova K; Simunek T
Chem Res Toxicol; 2011 Mar; 24(3):290-302. PubMed ID: 21214215
[TBL] [Abstract][Full Text] [Related]
30. The antioxidant effects of a novel iron chelator salicylaldehyde isonicotinoyl hydrazone in the prevention of H(2)O(2) injury in adult cardiomyocytes.
Horackova M; Ponka P; Byczko Z
Cardiovasc Res; 2000 Aug; 47(3):529-36. PubMed ID: 10963725
[TBL] [Abstract][Full Text] [Related]
31. Iron chelators: correlation between effects on Plasmodium spp. and immune functions.
Golenser J; Domb A; Mordechai-Daniel T; Leshem B; Luty A; Kremsner P
J Parasitol; 2006 Feb; 92(1):170-7. PubMed ID: 16629332
[TBL] [Abstract][Full Text] [Related]
32. Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.
Bogdanović G; Kojić V; Dordević A; Canadanović-Brunet J; Vojinović-Miloradov M; Baltić VV
Toxicol In Vitro; 2004 Oct; 18(5):629-37. PubMed ID: 15251181
[TBL] [Abstract][Full Text] [Related]
33. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs.
Becker E; Richardson DR
J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945
[TBL] [Abstract][Full Text] [Related]
34. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide.
Dhanasekaran A; Kotamraju S; Karunakaran C; Kalivendi SV; Thomas S; Joseph J; Kalyanaraman B
Free Radic Biol Med; 2005 Sep; 39(5):567-83. PubMed ID: 16085176
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
[TBL] [Abstract][Full Text] [Related]
36. Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.
Hermes-Lima M; Gonçalves MS; Andrade RG
Mol Cell Biochem; 2001 Dec; 228(1-2):73-82. PubMed ID: 11855743
[TBL] [Abstract][Full Text] [Related]
37. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages.
Stroh A; Zimmer C; Gutzeit C; Jakstadt M; Marschinke F; Jung T; Pilgrimm H; Grune T
Free Radic Biol Med; 2004 Apr; 36(8):976-84. PubMed ID: 15059638
[TBL] [Abstract][Full Text] [Related]
38. Cold-induced injury to lung epithelial cells can be inhibited by iron chelators - implications for lung preservation.
Pizanis N; Gillner S; Kamler M; de Groot H; Jakob H; Rauen U
Eur J Cardiothorac Surg; 2011 Oct; 40(4):948-55. PubMed ID: 21398140
[TBL] [Abstract][Full Text] [Related]
39. Chelation of lysosomal iron protects against ionizing radiation.
Berndt C; Kurz T; Selenius M; Fernandes AP; Edgren MR; Brunk UT
Biochem J; 2010 Dec; 432(2):295-301. PubMed ID: 20846118
[TBL] [Abstract][Full Text] [Related]
40. An endogenous metabolite of dopamine, 3,4-dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury.
Hashimoto T; Ibi M; Matsuno K; Nakashima S; Tanigawa T; Yoshikawa T; Yabe-Nishimura C
Free Radic Biol Med; 2004 Mar; 36(5):555-64. PubMed ID: 14980700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
